# A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy

> **NCT01597739** · PHASE2 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 96 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** JNJ-40346527
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01597739
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2014-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597739, "A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01597739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*